Safety and Immunogenicity of BBV121

NCT04478656 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Zika Virus Infection

Interventions

BIOLOGICAL: BBV121

Sponsor

Bharat Biotech International Limited